These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
452 related articles for article (PubMed ID: 2580857)
1. Cholecystokinin bioactivity in human plasma. Molecular forms, responses to feeding, and relationship to gallbladder contraction. Liddle RA; Goldfine ID; Rosen MS; Taplitz RA; Williams JA J Clin Invest; 1985 Apr; 75(4):1144-52. PubMed ID: 2580857 [TBL] [Abstract][Full Text] [Related]
2. Bioassay of plasma cholecystokinin in rats: effects of food, trypsin inhibitor, and alcohol. Liddle RA; Goldfine ID; Williams JA Gastroenterology; 1984 Sep; 87(3):542-9. PubMed ID: 6204904 [TBL] [Abstract][Full Text] [Related]
3. [Bioassay for plasma cholecystokinin bioactivity]. Sun G Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1991 Dec; 13(6):417-21. PubMed ID: 1724414 [TBL] [Abstract][Full Text] [Related]
4. Role of CCK in regulation of pancreaticobiliary functions and GI motility in humans: effects of loxiglumide. Schmidt WE; Creutzfeldt W; Schleser A; Choudhury AR; Nustede R; Höcker M; Nitsche R; Sostmann H; Rovati LC; Fölsch UR Am J Physiol; 1991 Feb; 260(2 Pt 1):G197-206. PubMed ID: 1996640 [TBL] [Abstract][Full Text] [Related]
5. Cholecystokinin receptor antagonist loxiglumide: influence on bilio-pancreatic secretion and gastrointestinal hormones in man. Schmidt WE; Creutzfeldt W; Höcker M; Choudhury AR; Nustede R; Schleser A; Nitsche R; Rovati LC; Schafmayer A; Fölsch UR Digestion; 1990; 46 Suppl 2():232-9. PubMed ID: 2262057 [TBL] [Abstract][Full Text] [Related]
6. Effects of a novel cholecystokinin (CCK) receptor antagonist, MK-329, on gallbladder contraction and gastric emptying in humans. Implications for the physiology of CCK. Liddle RA; Gertz BJ; Kanayama S; Beccaria L; Coker LD; Turnbull TA; Morita ET J Clin Invest; 1989 Oct; 84(4):1220-5. PubMed ID: 2794058 [TBL] [Abstract][Full Text] [Related]
7. Effects of intravenous infusion of amino acids on cholecystokinin release and gallbladder contraction in humans. Shirohara H; Tabaru A; Otsuki M J Gastroenterol; 1996 Aug; 31(4):572-7. PubMed ID: 8844480 [TBL] [Abstract][Full Text] [Related]
8. [Plasma cholecystokinin concentration in patients with chronic pancreatitis measured by bioassay]. Koide M; Okabayashi Y; Hasegawa H; Tani S; Fujisawa T; Nakamura T; Fujii M; Otsuki M Nihon Shokakibyo Gakkai Zasshi; 1989 Oct; 86(10):2419-24. PubMed ID: 2480463 [TBL] [Abstract][Full Text] [Related]
9. Physiological plasma concentrations of cholecystokinin stimulate pancreatic enzyme secretion and gallbladder contraction in man. Kerstens PJ; Lamers CB; Jansen JB; de Jong AJ; Hessels M; Hafkenscheid JC Life Sci; 1985 Feb; 36(6):565-9. PubMed ID: 3968978 [TBL] [Abstract][Full Text] [Related]
11. Postprandial release of cholecystokinin and pancreatic polypeptide in health and in gallstone disease: relationships with gallbladder contraction. Glasbrenner B; Domínguez-Muñoz JE; Nelson DK; Pieramico O; Holzwarth C; Riepl RL; Malfertheiner P Am J Gastroenterol; 1994 Mar; 89(3):404-10. PubMed ID: 8122654 [TBL] [Abstract][Full Text] [Related]
13. Comparison of the effects of cholecystokinin and cholecystokinin octapeptide on pancreatic secretion, gallbladder contraction, and plasma pancreatic polypeptide in man. Regan PT; Go VL; DiMagno EP J Lab Clin Med; 1980 Oct; 96(4):743-8. PubMed ID: 7419959 [TBL] [Abstract][Full Text] [Related]
14. Effect of intravenous fat on cholecystokinin secretion and gallbladder motility in man. de Boer SY; Masclee AA; Jebbink MC; Schipper J; Jansen JB; Lamers CB JPEN J Parenter Enteral Nutr; 1992; 16(1):16-9. PubMed ID: 1738213 [TBL] [Abstract][Full Text] [Related]
15. Gallbladder dynamics and plasma cholecystokinin responses after meals, oral water, or sham feeding in healthy subjects. Yamamura T; Takahashi T; Kusunoki M; Kantoh M; Seino Y; Utsunomiya J Am J Med Sci; 1988 Feb; 295(2):102-7. PubMed ID: 3344757 [TBL] [Abstract][Full Text] [Related]
16. Bioassay of plasma cholecystokinin in rat and human: inhibition of protein synthesis prevents the decrease in the sensitivity and responsiveness of isolated rat pancreatic acini to CCK-8. Otsuki M; Okabayashi Y; Nakamura T; Fujii M; Tani S; Fujisawa T; Koide M; Baba S Pancreas; 1989; 4(4):447-51. PubMed ID: 2474813 [TBL] [Abstract][Full Text] [Related]
17. CCK receptor antagonism by loxiglumide and gall bladder contractions in response to cholecystokinin, sham feeding and ordinary feeding in man. Konturek JW; Konturek SJ; Kurek A; Bogdal J; Oleksy J; Rovati L Gut; 1989 Aug; 30(8):1136-42. PubMed ID: 2767511 [TBL] [Abstract][Full Text] [Related]
18. Effect of aging on gallbladder contraction and release of cholecystokinin-33 in humans. Khalil T; Walker JP; Wiener I; Fagan CJ; Townsend CM; Greeley GH; Thompson JC Surgery; 1985 Sep; 98(3):423-9. PubMed ID: 4035564 [TBL] [Abstract][Full Text] [Related]
19. Determination of plasma cholecystokinin (CCK) concentrations by bioassay and radioimmunoassay in man. A critical evaluation. Höcker M; Schmidt WE; Creutzfeldt W; Choudhury AR; Nustede R; Schafmayer A; Fölsch UR Regul Pept; 1992 Feb; 37(3):255-69. PubMed ID: 1557514 [TBL] [Abstract][Full Text] [Related]
20. Stimulated gastrointestinal hormone release and gallbladder contraction during continuous jejunal feeding in patients with pancreatic pseudocyst is inhibited by octreotide. Takács T; Hajnal F; Németh J; Lonovics J; Pap A Int J Pancreatol; 2000 Dec; 28(3):215-20. PubMed ID: 11373059 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]